Isabel Fuentes-Calvo

Isabel Fuentes-Calvo

Auto-generated profile, based on publicly available information

Isabel Fuentes-Calvo

Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2013 in Hypertension
Verified
Journal Article
Closed access
PDF file
SGSuborno M. Ghosh
Suborno M. Ghosh
VKVikas Kapil
Vikas Kapil
IFIsabel Fuentes-Calvo
Isabel Fuentes-Calvo
KBKristen J. Bubb
Kristen J. Bubb
VPVanessa Pearl
Vanessa Pearl
AAAmrita AHLUWALIA
Amrita AHLUWALIA
Elevation of circulating nitrite (NO 2 − ) levels causes vasodilatation and lowers blood pressure in healthy volunteers. Whether these effects and the underpinning mechanisms persist in hypertension is unknown. Therefore, we investigated the consequences of systemic nitrite elevation in spontaneously hypertensive rats and conducted proof-of-principle studies in patients. Nitrite caused dose-dependent blood pressure–lowering that was profoundly enhanced in spontaneously hypertensive rats versus normotensive Wistar Kyoto controls. This effect was virtually abolished by the xanthine oxidoreductase (XOR) inhibitor, allopurinol, and associated with hypertension-specific XOR-dependent nitrite reductase activity localized to the erythrocyte but not the blood vessel wall. To determine whether these pathways translate to human hypertension, we investigated the effects of elevation of circulating nitrite levels in 15 drug naïve grade 1 hypertensives. To elevate nitrite, we used a dose of dietary nitrate (≈3.5 mmol) that elevated nitrite levels ≈1.5-fold ( P <0.01); a rise shown previously to exert no significant blood pressure–lowering effects in normotensives. This dose caused substantial reductions in systolic (≈12 mm Hg) and diastolic blood pressures ( P <0.001) and pulse wave velocity ( P <0.05); effects associated with elevations in erythrocytic XOR expression and XOR-dependent nitrite reductase activity. Our observations demonstrate the improved efficacy of inorganic nitrate and nitrite in hypertension as a consequence of increased erythrocytic XOR nitrite reductase activity and support the concept of dietary nitrate supplementation as an effective, but simple and inexpensive, antihypertensive strategy.

1 October 2013 in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
Verified
Journal Article
Closed access
AUAlvaro Conrado Ucero
Alvaro Conrado Ucero
ABAlberto Benito-Martin
Alberto Benito-Martin
IFIsabel Fuentes-Calvo
Isabel Fuentes-Calvo
BSBeatriz Santamaria
Beatriz Santamaria
JBJulia Blanco
Julia Blanco
AOAlberto Ortiz
Alberto Ortiz

1 March 2010 in Kidney International
Verified
Journal Article
Closed access
MGM. Teresa Grande
M. Teresa Grande
IFIsabel Fuentes-Calvo
Isabel Fuentes-Calvo
MAMiguel Arévalo
Miguel Arévalo
FHFabiana Heredia
Fabiana Heredia
ESEugenio Santos
Eugenio Santos
JLJosé M Lopez-Novoa
José M Lopez-Novoa

1 July 2006 in Experimental Cell Research
Verified
Journal Article
Closed access
CMCarlos Martínez-Salgado
Carlos Martínez-Salgado
IFIsabel Fuentes-Calvo
Isabel Fuentes-Calvo
GGGarcía García García
García García García
ESEugenio Santos
Eugenio Santos
JLJosé M Lopez-Novoa
José M Lopez-Novoa

1 January 2020 in Revista Espanola de Cardiologia
Verified
Journal Article
Closed access
MGMarta Gómez-Sánchez
Marta Gómez-Sánchez
Carmen Patino-AlonsoCarmen Patino-Alonso
Carmen Patino-Alonso
LGLeticia Gómez-Sánchez
Leticia Gómez-Sánchez
JRJosé I. Recio-Rodríguez
José I. Recio-Rodríguez
EREmiliano Rodríguez-Sánchez
Emiliano Rodríguez-Sánchez
IFIsabel Fuentes-Calvo
Isabel Fuentes-Calvo

1 July 2015 in Medicine
Verified
Journal Article
Open access
LGLuis Gamella-Pozuelo
Luis Gamella-Pozuelo
IFIsabel Fuentes-Calvo
Isabel Fuentes-Calvo
MGManuel A. Gómez-Marcos
Manuel A. Gómez-Marcos
JRJose Recio-Rodriguez
Jose Recio-Rodriguez
CACristina Agudo-Conde
Cristina Agudo-Conde
CMCarlos Martinez-Salgado
Carlos Martinez-Salgado
The search for biomarkers of hypertension and diabetes-induced damage to multiple target organs is a priority. We analyzed the correlation between plasma cardiotrophin-1 (CT-1), a chemokine that participates in cardiovascular remodeling and organ fibrosis, and a wide range of parameters currently used to diagnose morphological and functional progressive injury in left ventricle, arteries, and kidneys of diabetic and hypertensive patients, in order to validate plasma levels of CT-1 as clinical biomarker. This is an observational study with 93 type 2-diabetic patients, 209 hypertensive patients, and 82 healthy controls in which we assessed the following parameters: plasma CT-1, basal glycaemia, systolic blood pressure (SBP), diastolic blood pressure (DBP), pulse pressure (PP), left ventricular hypertrophy (LVH by electrocardiographic indexes), peripheral vascular disease (by pulse wave velocity—PWV, carotid intima-media thickness—C-IMT, and ankle-brachial index—ABI), and renal impairment (by microalbuminuria, albumin/creatinine urinary ratio, plasma creatinine concentrations, and glomerular filtration rate). Hypertensive or diabetic patients have higher plasma CT-1 than control patients. CT-1 positively correlates with basal glycaemia, SBP, DBP, PP, LVH, arterial damage (increased IMT, decreased ABI), and early renal damage (microalbuminuria, elevated albumin/creatinine ratio). CT-1 also correlates with increased 10-year cardiovascular risk. Multiple linear regression analysis confirmed that CT-1 was associated with arterial injury assessed by PWV, IMT, ABI, and cardiac damage evaluated by Cornell voltage duration product. Increases in plasma CT-1 are strongly related to the intensity of several parameters associated to target organ damage supporting further investigation of its diagnostic capacity as single biomarker of cardiovascular injury and risk and, possibly, of subclinical renal damage.